Acute Myeloid Leukemia | Topics

 
Advancements in Immunotherapies With John DiPersio, MD, PhD
September 13, 2021

The latest episode of the ASTCT Talks episode features John DiPersio, MD, PhD, on emerging therapies in the treatment of acute myeloid leukemia.

Association Seen Between MRD and First Remission/Outcomes in Intermediate-Risk Acute Myeloid Leukemia
September 08, 2021

Clinical decision-making based on minimal residual disease may be associated with improved therapy satisfaction and optimized post-remission treatment for patients with intermediate-risk acute myeloid leukemia.

Romyelocel-L Lowers Infection Risk During Induction Chemotherapy in Acute Myeloid Leukemia
September 02, 2021

The risk of infection during induction chemotherapy decreased among patients with acute myeloid leukemia treated with romyelocel-L.